share_log

华邦健康(002004.SZ):目前汉江药业上市事项尚未确定具体时间表

Huapont Life Sciences (002004.SZ): The specific timetable for Hanjiang Pharmaceutical's listing has not yet been determined.

Gelonghui Finance ·  Jul 16 04:50

On July 16th, Huapont Life Sciences (002004.SZ) stated on the investor interaction platform that Hanjiang Pharmaceutical is a subsidiary of the company, mainly engaged in the research and development, production, and sales of pharmaceutical active ingredients and intermediates, covering products such as corticosteroids, anthelmintic, respiratory system, and digestive system, and has established long-term cooperation relationships with internationally renowned pharmaceutical companies such as Abbott Laboratories, Johnson & Johnson, Eli Lilly and Co, and Merck. The specific timetable for the listing of Hanjiang Pharmaceuticals has not yet been determined, but Hanjiang Pharmaceuticals has the possibility of being listed based on its business and operating performance, and the specific situation should be based on the company's announcement information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment